Berlin, Germany - Nia Health GmbH, a pioneering medical equipment manufacturing company based in Berlin, is proud to announce the successful completion of its seed funding round, raising an impressive $3,748,000. The investment was led by HTGF | High-Tech Gründerfonds, a leading German venture capital firm, with participation from adesso ventures, a prominent investor in digital healthcare solutions.

Nia Health is on a mission to alleviate the burden and stigmatization faced by individuals with chronic skin conditions by offering an innovative and comprehensive platform for medical software. The company's flagship product, the award-winning eczema app called Nia, represents the first of many groundbreaking solutions developed by Nia Health.

Chronic skin conditions, such as eczema, often have a profound impact on individuals' quality of life. The Nia app provides patients with a user-friendly interface and a range of features designed to assist them in managing their condition effectively. The app incorporates advanced technology, including artificial intelligence and machine learning algorithms, to provide personalized insights, treatment recommendations, and real-time support. By empowering patients to take control of their health and well-being, Nia Health aims to significantly improve their overall quality of life.

The seed funding round, which secured $3.75 million, will enable Nia Health to accelerate its product development efforts and expand its reach to a wider audience. The investment will be utilized to enhance the capabilities of the Nia app, conduct clinical trials, and scale the company's operations. Nia Health plans to leverage this funding to establish strategic partnerships with key stakeholders in the medical industry, further bolstering its position as a leader in medical software solutions for chronic skin conditions.

Oliver Welter, Co-Founder of Nia Health GmbH, expressed his gratitude and enthusiasm for the successful funding round. He said, "We are thrilled to have the support of HTGF and adesso ventures as we continue our mission to improve the lives of individuals living with chronic skin conditions. This funding will be instrumental in driving innovation, expanding our product offerings, and ultimately making a positive impact on patient's lives."